Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Cati Racca, Jeske Joanna Katarina van Diemen, Wessel Willem Fuijkschot, Karlinde Spit, Tobias Nicolaas Bonten, Mattijs Everard Numans, Johanna Gerarda van der Bom, Yvo Michiel Smulders & Abel Thijs. (2019) Aspirin intake in the morning is associated with suboptimal platelet inhibition, as measured by serum Thromboxane B2, during infarct-prone early-morning hours. Platelets 30:7, pages 871-877.
Read now
Read now
Belete Biadgo, Mulugeta Melku, Solomon Mekonnen Abebe & Molla Abebe. (2016) Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity 9, pages 91-99.
Read now
Read now
Aung Myat, Udaya S. Tantry, Jacek Kubica & Paul A. Gurbel. (2016) Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events. Expert Review of Cardiovascular Therapy 14:12, pages 1361-1370.
Read now
Read now
Kevin P. Bliden, Udaya S. Tantry, Rahul Chaudhary, Seunghwan Byun & Paul A. Gurbel. (2016) Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events. Expert Review of Cardiovascular Therapy 14:7, pages 779-791.
Read now
Read now
Jeske Joanna Katarina van Diemen, Wessel Willem Fuijkschot, Tim Jon Wessels, Gerrit Veen, Yvo Michiel Smulders & Abel Thijs. (2016) Evening intake of aspirin is associated with a more stable 24-h platelet inhibition compared to morning intake: a study in chronic aspirin users. Platelets 27:4, pages 351-356.
Read now
Read now
Mette Tiedemann Skipper, Peter Rubak, Ole Halfdan Larsen & Anne-Mette Hvas. (2016) Thrombocytopenia model with minimal manipulation of blood cells allowing whole blood assessment of platelet function. Platelets 27:4, pages 295-300.
Read now
Read now
David S. H. Bell. (2016) Aspirin in the prevention of cardiovascular events in patients with diabetes. Postgraduate Medicine 128:2, pages 180-190.
Read now
Read now
Articles from other publishers (19)
Mikael Christiansen, Erik Lerkevang Grove & Anne-Mette Hvas. (2021) Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives. Seminars in Thrombosis and Hemostasis 47:07, pages 800-814.
Crossref
Crossref
Jia Su, Qinglin Yu, Jin Yang, Nan Zheng, Jinyan Zhong, Lindan Ji, Jiyi Li & Xiaomin Chen. (2021) The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility. Basic & Clinical Pharmacology & Toxicology 129:3, pages 196-209.
Crossref
Crossref
Salman Bhat, Yan Yatsynovich & Umesh C Sharma. (2021) Coronary revascularization in patients with stable coronary disease and diabetes mellitus. Diabetes and Vascular Disease Research 18:2, pages 147916412110024.
Crossref
Crossref
Beatrice Mainoli, Gonçalo S. Duarte, João Costa, Joaquim Ferreira & Daniel Caldeira. (2020) Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs 21:1, pages 63-71.
Crossref
Crossref
E. Paven, J.-G. Dillinger, C. Bal dit Sollier, T. Vidal-Trecan, N. Berge, R. Dautry, J.-F. Gautier, L. Drouet, J.-P. Riveline & P. Henry. (2020) Determinants of aspirin resistance in patients with type 2 diabetes. Diabetes & Metabolism 46:5, pages 370-376.
Crossref
Crossref
L. Vernstrøm, E. Laugesen, E. L. Grove, J. M. Baier, S. Gullaksen, A.‐M. Hvas, P. L. Poulsen & K. L. Funck. (2019) Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes. Diabetic Medicine 36:9, pages 1141-1148.
Crossref
Crossref
Morten Krogh Christiansen, Sanne Bøjet Larsen, Mette Nyegaard, Søs Neergaard-Petersen, Morten Würtz, Erik Lerkevang Grove, Anne-Mette Hvas, Henrik Kjærulf Jensen & Steen Dalby Kristensen. (2019) The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease. International Journal of Cardiology 286, pages 152-158.
Crossref
Crossref
Nicholas B. Norgard, Priya Jain & Jonathon R. Enriquez. 2019. Frontiers in Cardiovascular Drug Discovery: Volume 4. Frontiers in Cardiovascular Drug Discovery: Volume 4
1
15
.
Samuel Antwi-Baffour, Ransford Kyeremeh, Samuel Owusu Boateng, Lawrence Annison & Mahmood Abdulai Seidu. (2018) Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana. Lipids in Health and Disease 17:1.
Crossref
Crossref
Kingsley C. Agu. (2018) Diabetes mellitus: A review of some of the prognostic markers of response to treatment and management. Journal of Insulin Resistance 3:1.
Crossref
Crossref
Liv Vernstrøm, Kristian Løkke Funck, Erik Lerkevang Grove, Esben Laugesen, Jonathan Mathias Baier, Anne-Mette Hvas & Per Løgstrup Poulsen. (2018) Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease. Thrombosis Research 161, pages 1-6.
Crossref
Crossref
Mark R. Thomas, Dominick J. Angiolillo, Marc P. Bonaca, Ramzi A. Ajjan, Heather M. Judge, Fabiana Rollini, Francesco Franchi, Arif J. Ahsan, Deepak L. Bhatt, Julia F. Kuder, Philippe Gabriel Steg, Marc Cohen, Rangasamy Muthusamy, Marc S. Sabatine & Robert F. Storey. (2017) Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status. Thrombosis and Haemostasis 117:05, pages 940-947.
Crossref
Crossref
Wenqing Wang, Wayne Bond Lau, Yajing Wang, Xinliang Ma & Rong Li. (2016) Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals. Cardiovascular Diabetology 15:1.
Crossref
Crossref
Paul A. Gurbel, Kevin P. Bliden, Rahul Chaudhary, Jeff Patrick, Fang Liu, Gailing Chen, Christopher McLeod & Udaya S. Tantry. (2016) Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology 118:12, pages 1941-1947.
Crossref
Crossref
Mikhail S. Dzeshka, Alena Shantsila & Gregory Y. H. Lip. (2016) Effects of Aspirin on Endothelial Function and Hypertension. Current Hypertension Reports 18:11.
Crossref
Crossref
Dirk Sibbing, Lisa Gross & Dániel Aradi. (2017) Prevention of cardiovascular events with antiplatelet treatment: does time of intake matter for aspirin and ADP receptor blockers?. Thrombosis and Haemostasis 115:01, pages 3-6.
Crossref
Crossref
Søs Neergaard-Petersen, Anne-Mette Hvas, Erik Lerkevang Grove, Sanne Bøjet Larsen, Søren Gregersen & Steen Dalby Kristensen. (2015) The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin. PLOS ONE 10:7, pages e0132629.
Crossref
Crossref
Matthias Freynhofer, Susanne Gruber, Erik Grove, Thomas Weiss, Johann Wojta & Kurt Huber. (2017) Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thrombosis and Haemostasis 114:09, pages 459-468.
Crossref
Crossref
Erik Grove, Robert Storey & Steen Kristensen. (2017) Can we improve the efficacy of low-dose aspirin?. Thrombosis and Haemostasis 112:12, pages 1077-1078.
Crossref
Crossref